wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38592363-27F6D276-92BE-43AD-98C9-C7A189C2DF84
Q38592363-27F6D276-92BE-43AD-98C9-C7A189C2DF84
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38592363-27F6D276-92BE-43AD-98C9-C7A189C2DF84
Biosimilars in immune-mediated inflammatory diseases: initial lessons from the first approved biosimilar anti-tumour necrosis factor monoclonal antibody.
P2860
Q38592363-27F6D276-92BE-43AD-98C9-C7A189C2DF84
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38592363-27F6D276-92BE-43AD-98C9-C7A189C2DF84
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
548318eeb1ac78c0fba964b7292bdfad0fd79487
P2860
Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries.